GR 95168
Alternative Names: ADDR 84231; C-BVDULatest Information Update: 10 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antivirals; Nucleotides; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Herpes simplex virus infections; Varicella zoster virus infections
Most Recent Events
- 27 Jan 1995 Discontinued-Preclinical for Herpes simplex virus infections in United Kingdom (Unknown route)
- 27 Jan 1995 Discontinued-Preclinical for Varicella zoster virus infections in United Kingdom (Unknown route)